PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation (PRCT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · PRCT · as of Sep 30, 2025
Ownership Breakdown
264
Institutional Holders
▼ 18 vs Q2
$2.06B
Total Inst. Value
▼ $1.01B vs Q2
56.92M
Shares Outstanding
freeFloat 96.13%
57.85M
13F Shares Held
▲ 4.52M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
PRCT largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FMR LLC surgical & medical instruments & apparatus | 8.04M | 14.49% | 14.49% | $286.81B | Nov 13, 2025 | ▲ 236.4K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 5.21M | 9.39% | 9.39% | $185.78B | Nov 7, 2025 | ▼ 42.6K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 4.22M | 7.61% | 7.61% | $150.63B | Nov 12, 2025 | ▲ 12.3K |
ALLIANCEBERNSTEIN L.P. surgical & medical instruments & apparatus | 3.42M | 6.17% | 6.17% | $122.05B | Nov 14, 2025 | ▲ 1.26M |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. surgical & medical instruments & apparatus | 2.05M | 3.70% | 3.70% | $73.26B | Nov 14, 2025 | ▲ 524.8K |
WESTFIELD CAPITAL MANAGEMENT CO LP surgical & medical instruments & apparatus | 1.97M | 3.55% | 3.55% | $70.31B | Nov 12, 2025 | ▲ 371.8K |
CHICAGO CAPITAL, LLC surgical & medical instruments & apparatus | 1.57M | 2.83% | 2.83% | $55.99B | Oct 22, 2025 | ▲ 999.9K |
MACKENZIE FINANCIAL CORP surgical & medical instruments & apparatus | 1.45M | 2.62% | 2.62% | $51.91B | Nov 13, 2025 | ▲ 745.8K |
CHAMPLAIN INVESTMENT PARTNERS, LLC surgical & medical instruments & apparatus | 1.44M | 2.59% | 2.59% | $51.32B | Nov 12, 2025 | ▲ 367.3K |
ARTISAN PARTNERS LIMITED PARTNERSHIP surgical & medical instruments & apparatus | 1.37M | 2.46% | 2.46% | $48.72B | Nov 12, 2025 | ▲ 378.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
32
Increased
+8.54M shares2
New Positions
first time holders13
Decreased
−1.55M shares0
Sold Out
fully exitedNet shares change (top 50)
+6.98M
+8.54M / −1.55M
Net new holders
+21
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
PRCT insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
17
Buy transactions
8
Sell transactions
2.13
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Nouri Alaleh EVP, CLO, CORP. SEC. | Mar 19, 2026 | Sale | 3,031 | $25.82 | $78.3K | 107.7K | Form 4 ↗ |
Nouri Alaleh EVP, CLO, CORP. SEC. | Mar 19, 2026 | Sale | 2,332 | $26.15 | $61.0K | 105.4K | Form 4 ↗ |
Nouri Alaleh EVP, CLO, CORP. SEC. | Mar 17, 2026 | Sale | 304 | $28.15 | $8.6K | 110.7K | Form 4 ↗ |
Waters Kevin EVP, CFO | Mar 17, 2026 | Sale | 706 | $28.15 | $19.9K | 151.6K | Form 4 ↗ |
Nouri Alaleh EVP, CLO, CORP. SEC. | Mar 10, 2026 | Sale | 3,098 | $25.60 | $79.3K | 111.2K | Form 4 ↗ |
Nouri Alaleh EVP, CLO, CORP. SEC. | Mar 10, 2026 | Sale | 145 | $26.74 | $3.9K | 111.0K | Form 4 ↗ |
Desai Antal Rohit director | Mar 9, 2026 | Purchase | 1,300 | $25.42 | $33.0K | 426.3K | Form 4 ↗ |
Desai Antal Rohit director | Mar 9, 2026 | Purchase | 53,818 | $24.91 | $1.34M | 425.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
PROCEPT BioRobotics Corporation (PRCT) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 3.87%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of PROCEPT BioRobotics Corporation is FMR LLC, holding approximately 8.04 million shares — equal to 14.49% of outstanding shares — as of September 30, 2025.
A total of 264 institutional investors currently hold PRCT stock, with a combined institutional value of approximately $2.06 billion as of the most recent 13F filing period.
Frequently asked questions
PRCT ownershipPROCEPT BioRobotics Corporation (PRCT) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is FMR LLC with a 14.49% stake. Company insiders hold 3.87%. Data sourced from SEC Form 13F as of September 30, 2025.